Experimental cancer injection tested in small safety trial
NCT ID NCT06182579
Summary
This early-stage study tested a new drug called RiMO-401, injected directly into tumors along with radiation therapy, for people with advanced cancers. The main goal was to find a safe dose and check for side effects in a small group of 5 participants. The study was terminated early and focused on patients whose tumors could be reached for injection and radiation treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Illinois at Chicago
Chicago, Illinois, 60612, United States
Conditions
Explore the condition pages connected to this study.